Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhuaqingwen Granules for non-influenza viral pneumonia
ChiCTR-IPR-16007773Phase 4Not yet recruiting
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2015
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingwen in viral pneumonia and community-acquired pneumonia (CAP) (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: Clinical symptom. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
Lianhua Qingwen
03
Conditions
viral pneumoniacommunity-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR-IPR-16007773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007773.